<table class="infobox infobox-protein"> <tr><th class="infobox-header" colspan="2">Mitochondrial Carrier Family (SLC25)</th></tr> <tr><td class="label">Gene Family</td><td>SLC25</td></tr> <tr><td class="label">Members</td><td>53 members in humans</td></tr> <tr><td class="label">Location</td><td>Inner mitochondrial membrane</td></tr> <tr><td class="label">Function</td><td>Metabolite transport across IMM</td></tr> <tr><td class="label">Structure</td><td>6 transmembrane helices</td></tr> </table>
Mitochondrial Carrier Family (SLC25)
Introduction
The Mitochondrial Carrier Family (MCF), also known as the SLC25 family, comprises 53 members in humans that function as transport proteins in the inner mitochondrial membrane (IMM). These carriers facilitate the movement of metabolites, nucleotides, amino acids, and cofactors across the IMM, which is otherwise impermeable to most molecules. The mitochondrial carrier family is essential for cellular metabolism, energy production, and cell survival. Given the central role of mitochondrial dysfunction in neurodegenerative diseases, the SLC25 family has emerged as a critical area of research for understanding and treating [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurological disorders [1].
Structure
All mitochondrial carriers share a common structural theme:
Common Architecture
Six transmembrane α-helices: Form the transport channel
Three repeated motifs: Each ~100 amino acids with conserved motifs
Substrate-binding site: Located in the center of the channel
Matrix and cytosolic gates: Regulate substrate access
Transport Mechanism
Most mitochondrial carriers operate as antiporters:
Exchange one substrate for another
Strict substrate specificity
Electrochemical gradient-driven
Structural Studies
Crystal structures of several carriers solved
Conformational changes during transport characterized
Provides targets for drug development
Key Family Members
Energy Metabolism Carriers
SLC25A4 (ANT1/ANC1) - ADP/ATP Translocase 1
Exchanges mitochondrial ATP for cytosolic ADP
Essential for ATP export to cytosol
Major component of mitochondrial permeability transition
SLC25A5 (ANT2) - ADP/ATP Translocase 2
Expressed in proliferating cells
Involved in mitochondrial DNA maintenance
SLC25A3 (PiC) - Phosphate Carrier
Imports inorganic phosphate for ATP synthesis
Essential for oxidative phosphorylation
SLC25A1 (CIC) - Citrate Carrier
Exports citrate from mitochondria
Links glycolysis to fatty acid synthesis
Amino Acid Carriers
SLC25A12 (AGC1) - Arginine/Glutamate Carrier
Exports glutamate, imports arginine
Important for neurotransmitter synthesis
SLC25A13 (AGC2) - Aspartate/Glutamate Carrier
Critical for malate-aspartate shuttle
Links cytosolic and mitochondrial metabolism
Coenzyme Carriers
SLC25A16 (GDC) - Glycine Decarboxylase Carrier
Involved in glycine metabolism
SLC25A42 - Coenzyme A Carrier
Imports CoA into mitochondria
Physiological Functions
Energy Production
The MCF is essential for oxidative phosphorylation:
ATP export: ADP/ATP translocases export newly synthesized ATP
Pi import: Phosphate carrier supplies phosphate for ATP synthesis
Substrate delivery: Provides substrates for the electron transport chain
Metabolic Regulation
Malate-Aspartate Shuttle:
Transfers reducing equivalents across IMM
Critical for NAD+ regeneration in cytosol
Citrate Shuttle:
Exports citrate for fatty acid synthesis
Links glycolysis to lipogenesis
Calcium Handling
Several carriers respond to calcium signals:
Mitochondrial calcium uptake
Metabolic adaptation to cellular demands
Nucleotide Metabolism
Mitochondrial DNA replication
Nucleotide import for mtDNA synthesis
Role in Neurodegeneration
Alzheimer's Disease
Mitochondrial carriers are affected in AD:
ADP/ATP Translocase (ANT):
Altered expression in AD brains [2]
Contributes to mitochondrial dysfunction
May facilitate [Aβ](/proteins/amyloid-beta)-induced toxicity
Phosphate Carrier:
Impaired phosphate transport in AD
Contributes to reduced ATP synthesis
Parkinson's Disease
Several SLC25 members are critical in PD:
SLC25A4 (ANT1):
Genetic variants associated with PD risk [3]
Altered function in PD brains
Contributes to energy failure
SLC25A10 - Mitochondrial Dicarboxylate Carrier:
Involved in glutathione transport
May affect oxidative stress in PD
Mitochondrial carriers and PINK1/Parkin:
Affected by mitophagy defects
Contribute to accumulation of dysfunctional mitochondria
Amyotrophic Lateral Sclerosis (ALS)
Altered mitochondrial transport
Energy failure in motor [neurons](/entities/neurons)
Mutant SOD1 affects carrier function
Huntington's Disease
Impaired energy metabolism
Altered mitochondrial carriers
Contributes to striatal neuron vulnerability
Therapeutic Implications
Mitochondrial carriers are promising drug targets:
Small Molecule Modulators
Transport inhibitors/activators
Metabolite analogs
Energy metabolism enhancers
Gene Therapy
AAV-mediated carrier expression
CRISPR-based approaches
Target-Specific Strategies
ANT-targeting compounds
PiC modulators
AGC1/AGC2 modulators
See Also
[Mitochondrial ATP Synthesis](/mechanisms/mitochondrial-atp-synthesis)